Rebuilding After Sa...
Health Care: Drugs
Cubist Pharmaceuticals Inc. (CBST: NASDAQ)
$56.11 0.65 | 1.17%
05/22/13 - 04:00 PM ET
Growth Rates
| GROWTH RATES |
|---|
| REVENUE (Trailing 12 Quarters) |
| EARNINGS PER SHARE (Trailing 12 Quarters) |
| DIVIDENDS (Trailing 12 Quarters) |
Portfolios with CBST
- Portfolio NameUser Type
- ContributorGARP Growers for Summer 2013
- ContributorEarnings Short Squeeze Play...
- ContributorStocks Rising On Unusual Vo...
- ContributorEarnings Short Squeeze Play...
- ContributorEarnings Short Squeeze Play...
- UserGFNN Stockdiagnostics 6
- ContributorStocks At New 52-Week Highs...
- ContributorTop-Rated Biotechnology Stocks
- ContributorEarnings Short Squeeze Play...
- ContributorStocks At New 52-Week Highs...
Latest CBST Headlines from TheStreet
- Cubist Pharmaceuticals Inc. (CBST): Today's Featured Health Care Winner 05.22.13 | 05:05 pm
- Cubist, Optimer, Trius: Antibiotic Deal Making On Tap 05.22.13 | 07:05 am
- Cubist Rises On Unusually High Volume (CBST) 05.21.13 | 12:05 pm
- Analysts' Actions: CBST CNW COH TMHC VFC 05.21.13 | 08:05 am
- 2013 FDA Drug Approval Calendar 05.21.13 | 07:05 am
- Cubist Reaches New 52-Week High (CBST) 05.20.13 | 10:05 am
- 4 GARP Growers to Buy This Summer 05.10.13 | 12:05 pm
- Cramer's Top Stock Picks: PPG ETN CBST NFLX 04.30.13 | 06:04 am
- Cramer's 'Mad Money' Recap: Dazed and Confused Markets 04.29.13 | 08:04 pm
- Cubist Rises On Unusually High Volume (CBST) 04.02.13 | 04:04 pm
Press Releases for CBST
- Cubist Obtains Remaining Rights To Ceftolozane From Astellas - Business Wire 03.11.13 | 08:03 am
- Michael Tomsicek, Cubist CFO (Photo: Business Wire) - Business Wire 03.04.13 | 07:03 am
- FDA Grants QIDP And Fast Track Designations For Cubist’s Late-Stage Antibiotic Candidates - Business Wire 02.28.13 | 04:02 pm
- Cubist Pharmaceuticals To Present At Cowen And Company 33rd Annual Health Care Conference - Business Wire 02.27.13 | 08:02 am
- Cubist Announces Exclusive Option To Acquire Adynxx - Business Wire 02.25.13 | 08:02 am
- Cubist To Present At February Investor Conferences - Business Wire 01.29.13 | 08:01 am
- Cubist Reports Fourth Quarter And Full Year 2012 Financial Results - Business Wire 01.23.13 | 04:01 pm
- Thomas J. DesRosier (Photo: Business Wire) - Business Wire 01.08.13 | 08:01 am
- Cubist Announces Full-Year 2012 Revenues And Provides Business Update - Business Wire 01.07.13 | 07:01 am
- Heptares Partners With Cubist To Research New Medicines Targeting GPCRs - PR Newswire 01.07.13 | 07:01 am
Partner Headlines for CBST
- Revenues Decline at Alnylam - Analyst Blog - Zacks 11.07.12 | 09:11 am
- Narrower Loss at Optimer - Analyst Blog - Zacks 11.02.12 | 05:11 pm
- Pipeline Progress at Cubist Pharma - Analyst Blog - Zacks 11.01.12 | 06:11 pm
- Stocks Tumble On Disappointing Earnings Reports - Investor's Business Daily 10.19.12 | 04:10 pm
- Stocks Hit Fresh Intraday Lows; Google Reverses Lower - Investor's Business Daily 10.19.12 | 03:10 pm
- Stocks Headed For Weaker Start; Polaris Motors Up - Investor's Business Daily 10.18.12 | 09:10 am
- After-Hours Earnings Report for October 18, 2012 : MSFT, GOOG, COF, SNDK, CMG, PBCT, FLEX, RHI, VMI, RVBD, CYT, CBST - NASDAQ 10.18.12 | 04:10 am
- After-Hours Earnings Report for October 18, 2012 : MSFT, GOOG, COF, SNDK, CMG, PBCT, FLEX, RHI, VMI, RVBD, CYT, CBST - NASDAQ 10.18.12 | 04:10 am
- Stocks Mixed In Afternoon Trade; Homebuilders Lead - Investor's Business Daily 10.17.12 | 01:10 pm
- Earnings Preview: Cubist Pharma - Analyst Blog - Zacks 10.17.12 | 09:10 am
